Temerty Researchers Achieve Breakthrough in Neurodegenerative Disease Treatment
A team led by Dr. Michael Torres has identified a novel therapeutic target for Alzheimer's disease, opening new avenues for treatment development.
The latest from Temerty Medicine alumni — breakthroughs, achievements, and community highlights.
A team led by Dr. Michael Torres has identified a novel therapeutic target for Alzheimer's disease, opening new avenues for treatment development.
Recognized for her pioneering work in global health and her efforts to improve maternal care in underserved communities across sub-Saharan Africa.
The state-of-the-art facility features advanced surgical simulators and AI-driven clinical training environments for students and residents.
The Temerty Global Health Partnership, founded by Dr. David Mensah (MD '97), has trained over 500 community health workers in Kenya and Tanzania.
A consortium led by Temerty Faculty researchers receives major CIHR funding to map genetic risk factors for heart disease in diverse populations.
Since its launch in 2018, the alumni mentorship program has connected over 1,000 student-mentor pairs, with a 94% satisfaction rate.
Honoured for developing a portable diagnostic device that enables rapid blood testing in remote and northern communities across Canada.
Developed in partnership with Indigenous communities, the new curriculum stream prepares students to address health disparities with cultural humility.
A collaborative effort between Temerty Medicine and Vector Institute researchers produces a breakthrough machine learning model for cancer detection.